Skip to main content
OpenTrials

Clinical trial condition

Metastatic Renal Cell Cancer

Explore clinical trials studying Metastatic Renal Cell Cancer. Study availability and eligibility vary by location and protocol.

23 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Metastatic Renal Cell Cancer trial results

Completed

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00027820

Conditions
Adenocarcinoma, Adult Acute Myeloid Leukemia in Remission, Anemia, +72 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Investigational Drug Service Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
View all 113 locations
View Trial Details
Completed

A Phase 1b Trial in Patients With Renal Cell Cancer

NCT01258348

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States
View Trial Details
Completed

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

NCT01743469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Gastric Carcinoma, +38 more
Locations
  • Antwerp University Hospital, Wilrijkstraat 10 Edegem, Belgium
  • Ghent University Hospital, 1K12 IE, De Pintelaan 185 Ghent, Belgium
  • Leuven cancer institute (LKI), Herestraat Leuven, Belgium
  • Juravinski Cancer Centre, 699 Concession St Hamilton, Ontario, Canada
View all 24 locations
View Trial Details
Completed

Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

NCT01462214

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Medisch Centrum Alkmaar Alkmaar, Netherlands
  • VU University Medical Center Amsterdam, Netherlands
  • NKI-AVL Amsterdam, Netherlands
  • Universitair Medisch Centrum Groningen Groningen, Netherlands
View all 13 locations
View Trial Details

Related conditions